EBIT: Income before interest and taxes.
Ventyx Biosciences, Inc. (VTYX) had EBIT of $-30.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-27.44M |
|
-- |
|
-- |
|
$30.10M |
|
$-30.10M |
|
$2.66M |
|
$-27.44M |
|
$-27.44M |
|
$-27.44M |
|
$-27.44M |
|
$-27.44M |
|
$-27.44M |
|
|
EBIT |
$-30.10M |
$-29.74M |
|
71.13M |
|
71.13M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$242.56M |
|
$0.52M |
|
$10.92M |
|
$253.48M |
|
$12.39M |
|
-- |
|
$9.45M |
|
$21.85M |
|
$231.63M |
|
$231.63M |
|
$231.63M |
|
71.16M |
|
| Cash Flow Statement Financials | |
$-25.72M |
|
$26.41M |
|
-- |
|
$28.23M |
|
$29.05M |
|
$0.82M |
|
$5.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.85% |
|
-11.85% |
|
-10.83% |
|
-11.85% |
|
$3.26 |
|
$-0.36 |
|
$-0.36 |
|